Determination Concerning a Petition To Add a Class of Employees to the Special Exposure Cohort, 36550 [2013-14389]
Download as PDF
<![CDATA[
36550
Federal Register / Vol. 78, No. 117 / Tuesday, June 18, 2013 / Notices
Parts Closed to the Public
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
1. Procurement
2. Security
CONTACT PERSON FOR MORE INFORMATION:
Kimberly Weaver, Director, Office of
External Affairs, (202) 942–1640.
[60Day–13–13XA]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Dated: June 13, 2013.
James B. Petri,
Secretary, Federal Retirement Thrift
Investment Board.
[FR Doc. 2013–14524 Filed 6–14–13; 11:15 am]
BILLING CODE 6760–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Determination Concerning a Petition
To Add a Class of Employees to the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention, Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice.
HHS gives notice of a
determination concerning a petition to
add a class of employees from the
Brookhaven National Laboratory in
Upton, New York, to the Special
Exposure Cohort (SEC) under the Energy
Employees Occupational Illness
Compensation Program Act of 2000
(EEOICPA). On June 7, 2013, the
Secretary of HHS determined that the
following class of employees does not
meet the statutory criteria for addition
to the SEC as authorized under
EEOICPA:
SUMMARY:
All employees of the Department of
Energy, its predecessor agencies, and its
contractors and subcontractors who worked
at Brookhaven National Laboratory in Upton,
New York, from January 1, 1994, to December
31, 2007.
mstockstill on DSK4VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 1–
877–222–7570. Information requests can
also be submitted by email to
DCAS@CDC.GOV.
Dated: June 11, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2013–14389 Filed 6–17–13; 8:45 am]
BILLING CODE 4163–19–P
VerDate Mar<15>2010
16:52 Jun 17, 2013
Jkt 229001
Centers for Disease Control and
Prevention
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Ron Otten, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Improving HIV Prevention and
Treatment Outcomes Among HIVInfected Persons by Integrating
Community Pharmacists and Clinical
Sites into a Model of Patient-Centered
HIV Care—New—National Center for
HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Medication Therapy Management
(MTM) is a group of pharmacist
provided services that is independent
of, but can occur in conjunction with,
provision of medication. Medication
Therapy Management encompasses a
broad range of professional activities
and cognitive services within the
licensed pharmacists’ scope of practice
and can include monitoring prescription
filling patterns and timing of refills,
checking for medication interactions,
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
patient education, and monitoring of
patient response to drug therapy.
HIV specific MTM programs have
demonstrated success in improving HIV
medication therapy adherence and
persistence. While MTM programs have
be shown to be effective in increasing
medication adherence for HIV-infected
persons, no MTM programs have been
expanded to incorporate primary
medical providers in an effort to
establish patient-centered HIV care. To
address this problem CDC has entered
into a public-private partnership with
Walgreen Company (a.k.a Walgreens
pharmacies, a national retail pharmacy
chain) to develop and implement a
model of HIV care that integrates
community pharmacists with primary
medical providers for patient-centered
HIV care. The model program will be
implemented in ten sites and will
provide patient-centered HIV care for
approximately 1,000 persons.
The patient-centered HIV care model
will include the core elements of MTM
as well as additional services such as
individualized medication adherence
counseling, active monitoring of
prescription refills and active
collaboration between pharmacists and
medical clinic providers to identify and
resolve medication related treatment
problems such as treatment
effectiveness, adverse events and poor
adherence. The expected outcomes of
the model program are increased
retention in HIV care, adherence to HIV
medication therapy and viral load
suppression.
CDC requests OMB approval to collect
standardized information, from ten
project sites over the three year project
period. CDC also requests approval to
conduct one cycle of retrospective data
collection during the first year of the
three year project period. The
retrospective data collection will
provide information about clients’
baseline characteristics prior to
participation in the model program
which is needed to compare outcomes
before and after program
implementation.
Pharmacy, laboratory and medical
data will be collected through
abstraction of all participant clients’
pharmacy and medical records.
Pharmacy, laboratory and medical data
are needed to monitor retention in care,
adherence to therapy, viral load
suppression and other health outcomes.
Program specific data, such as the
number of MTM elements completed
per project site will be collected by
program. Qualitative data will be
gathered from program staff through inperson or telephone interviews.
E:\FR\FM\18JNN1.SGM
18JNN1
]]>Agencies
[Federal Register Volume 78, Number 117 (Tuesday, June 18, 2013)]
[Notices]
[Page 36550]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14389]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Determination Concerning a Petition To Add a Class of Employees
to the Special Exposure Cohort
AGENCY: National Institute for Occupational Safety and Health (NIOSH),
Centers for Disease Control and Prevention, Department of Health and
Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: HHS gives notice of a determination concerning a petition to
add a class of employees from the Brookhaven National Laboratory in
Upton, New York, to the Special Exposure Cohort (SEC) under the Energy
Employees Occupational Illness Compensation Program Act of 2000
(EEOICPA). On June 7, 2013, the Secretary of HHS determined that the
following class of employees does not meet the statutory criteria for
addition to the SEC as authorized under EEOICPA:
All employees of the Department of Energy, its predecessor
agencies, and its contractors and subcontractors who worked at
Brookhaven National Laboratory in Upton, New York, from January 1,
1994, to December 31, 2007.
FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director,
Division of Compensation Analysis and Support, National Institute for
Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46,
Cincinnati, OH 45226, Telephone 1-877-222-7570. Information requests
can also be submitted by email to DCAS@CDC.GOV.
Dated: June 11, 2013.
John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 2013-14389 Filed 6-17-13; 8:45 am]
BILLING CODE 4163-19-P
